Sorafenib-Loaded Cu(2−x)Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) accounts for the predominant form of liver malignancy and presents a leading cause of cancer-related death globally. Sorafenib (SOR), a first-line targeted drug for advanced HCC treatment, has a battery of untoward side effects. Photothermal therapy (PTT) has been util...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, An-Tian, Du, Jun, Liu, Zhi-Yong, Zhang, Guang-Cong, Abuduwaili, Weinire, Yan, Jia-Yan, Sun, Jia-Lei, Xu, Ru-Chen, Liu, Tao-Tao, Shen, Xi-Zhong, Dong, Ling, Zhu, Ji-Min, Li, Yuhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505850/
https://www.ncbi.nlm.nih.gov/pubmed/36144982
http://dx.doi.org/10.3390/nano12183191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505850/
https://www.ncbi.nlm.nih.gov/pubmed/36144982
http://dx.doi.org/10.3390/nano12183191

Ejemplares similares